Private Capital Management, LLC Harrow Health, Inc. Transaction History
Private Capital Management, LLC
- $830 Million
- Q4 2024
A detailed history of Private Capital Management, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Private Capital Management, LLC holds 1,694,983 shares of HROW stock, worth $49.1 Million. This represents 6.85% of its overall portfolio holdings.
Number of Shares
1,694,983
Previous 2,163,681
21.66%
Holding current value
$49.1 Million
Previous $97.3 Million
41.54%
% of portfolio
6.85%
Previous 11.41%
Shares
11 transactions
Others Institutions Holding HROW
# of Institutions
184Shares Held
21.1MCall Options Held
679KPut Options Held
1.27M-
Opaleye Management Inc. Boston, MA3.99MShares$116 Million26.33% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$62.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$54.2 Million0.0% of portfolio
-
Braidwell LP Stamford, CT907KShares$26.3 Million1.7% of portfolio
-
State Street Corp Boston, MA828KShares$24 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $784M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...